摘要
<正>3药用菌的生物医学应用蕈菌被应用于古老的传统疗法,至少可以追溯到新石器时代,几千年来,其一直被用作人类的食品和药品。当代研究证实并记录了许多关于药用菌的古老知识。药用菌的跨学科领域研究已经逐步发展,并论证了一系列从蕈菌中提取的化合物的有效性和独特性,尤其是在过去的三十年中。日本、中国、韩国、俄
引文
[1]Chang ST,Miles PG.Mushrooms:cultivation,nutritional value,medicinal effect,and environmental impact[M].Boca Raton(FL):CRC Press,2004:451.
[2]Bels PJ.Foreword.In Chang ST,Hayes WA,editors.The biology and cultivation of edible mushrooms[M].New York(NY):Academic Press,1976:819.
[3]Fava F,Totaro G,Diels L,et al.Biowaste biorefinery in Europe:opportunities and research and development needs[J].New Biotechnol,2015(32):100-108.
[4]Khan N,Roes-Hill M,Welz PJ,et al.Fruit waste streams in South Africa and their potential role in developing a bio-economy[J].S Afr J Sci,2015(111):1-11.
[5]Yang X,Choi HS,Park C,et al.Current states and prospects of organic waste utilization for biorefineries[J].Renew Sustain Energy Rev,2015(49):335-349.
[6]Jong E,Jungmeier G.Biorefinery concepts in comparison to petrochemical refineries[J].Ind Bioref White Biotechnol,2015(7):3-33.
[7]Chang ST,Miles PG.Recent trends in world production of cultivated mushrooms[J].Mushr J,1991(503):15-18.
[8]Miles PG,Chang ST.Mushroom biology:concise basics and current developments[M].London(UK):World Scientific,1997:1-194.
[9]Buswell JP,Cai YJ,Chang ST.Fungal-and substrate-associated factors affecting the ability of individual mushroom species to utilize different lignocellulosic growth substrates[A].In Chang ST,Buswell JA,Chiu SW,editors.Mushroom biology and mushroom products[M].Hong Kong:Chinese University Press,1993:141-150.
[10]Taofiq O,González-Paramás AM,Martins A,et al.Mushrooms extracts and compounds in cosmetics,cosmeceuticals and nutricosmetics-a review[J].Industr Crops Prod,2016(90):38-48.
[11]Buswell JA,Cai YJ,Chang ST,et al.Lignocellulolytic enzyme profile of edible mushroom fungi[J].World J Microbiol Biotechnol,1996(12):537-542.
[12]Chen S,Ma D,Ge W,et al.Induction of laccase activity in the edible straw mushroom,Volvariella volvacea[J].FEMSMicrobiol Lett,2003(218):143-148.
[13]Silva EM,Machuca A,Milagres AMF.Evaluation of the growth and enzyme production from Lentinula edodes strains[J].Process Biochem,2005(40):161-164.
[14]Elisashvili V,Penninckx M,Kachlishvili E,et al.Lentinus edodes and Pleurotus species lignocellulolytic enzymes activity in submerged and solid-state fermentation of lignocellulosic wastes of different composition[J].Biores Technol,2008(99):457-462.
[15]Elisashvili V,Kachlishvili E,Asatiani M.Shiitake medicinal mushroom,Lentinus edodes(higher Basidiomycetes)productivity and lignocellulolytic enzyme profiles during wheat straw and tree leaf bioconversion[J].Int J Med Mushrooms,2015,17(1):77-86.
[16]Zmitrovich IV,Wasser SP.Is widely cultivated“Pleurotus sajour-caju”especially in Asia,indeed an independent species?[J].Int J Med Mushrooms,2016,18(7):583-588.
[17]Cai YJ,Chapman SJ,Buswell JA,et al.Production and distribution of endoglucanase,cellobiohudrolase,and B-glucoidase components of the cellulolytic system of Volvariella volvacea,the edible straw mushroom[J].Appl Environment Microbiol,1999(65):553-559.
[18]Chang ST,Fernandes F.Mushroom,biogas and biofertilizer from organic wastes[J].Mushroom Newsl,1980(1):2.
[19]Mshigeni KE,Chang ST.Mushrooms,environment and human health[M].Dar-Es-Salaam(Tanzania):Mkuki Na Nyota,2013:1-151.
[20]Stamets P.Mycelium running:how mushrooms can help save the world[M].Berkeley(CA):Ten Speed Press,2005:1-339.
[21]Chang ST,Wasser SP.The role of culinary-medicinal mushrooms on human welfare with pyramid model for human health[J].Int J Med Mushrooms,2012,14(2):95-134.
[22]Chang ST,Wasser SP.The cultivation and environmental impact of mushrooms[A].In Oxford research encyclopedia of environmental science[M].New York(NY):Oxford University Press,2017.Retrieved from http://environmentalscience.oxfordre.com/view/10.1093/acrefore/9780199389414.001.0001/acrefore-9780199389414-e-231.
[23]Anke T,Oberwinkler F.The strobilurins new antifungal antibiotics from the basidiomycete Strobilurus tenacellus[J].J Antibiot,1977(30):806-810.
[24]Musilek V,Cerna J,Sasek V,et al.Antifungal antibiotic from the basidiomycete Oudemansiella mucida.I.Isolation and cultivation of a producing strain[M].Folia Microbiol,1969(14):377-388.
[25]Lorenzen K,Anke T.Basidiomycetes as source for new bioactive natural products[J].Curr Organ Chem,1998(2):329-364.
[26]Anke T,Werle A,Bross M,et al.Antibiotics from Basidiomycetes.XXXII.Oudemansin X,a new antifungal E-β-methoxyacrylate from Oudemansiella radicata(Relhan ex Fr.)Sing[J].J Antibiot,1990(43):1010-1011.
[27]Zjawiony JK.Active compounds from Aphyllophorales(Polypore)fungi[J].J Nat Prod,2004(67):300-310.
[28]Clough JM.The strobirulins,oudemansins,and myxothiazols,fungicidal derivatives of beta methoxyacrilic acid[J].Nat Prod Rep,1993,10(6):565-574.
[29]Knight SC,Anthony VM,Brady AM,et al.Rational and perspectives on the development of fungicides[J].Ann Rev Phytopathol,1997(35):349-372.
[30]Anke T,Werle A,Zapf S.Favolon,a new antifungal triterpenoid from Favolaschia species[J].J Antibiot,1995(48):725-726.
[31]Aqueveque P,Anke T,Anke H,et al.Favolon B,a new triterpenoid isolated from the Chilean Mycena sp.strain 96180[J].JAntibiot,2005,58(1):61-64.
[32]Kupka J,Anke T,Gianetti BM,et al.Antibiotics from Basidiomycetes.XIV.Isolation and biological characterisation of hypnophilin,pleurotellol,and pleurotellic acid from Pleurotellus hypnophilus(Berk.)Sacc[J].Arch Microbiol,1981(130):223-227.
[33]Lauer U,Anke T,Shledrick WS,et al.Antibiotics from Basidiomycetes.XXXI.Aleurodiscal:an antifungal sesquiterpenoid from Aleurodiscus mirabilis(Berk.&Curt.)H?hn[J].J Antibiot,1989(42):875-882.
[34]Arnone A,Cardillo R,Meille SV,et al.Secondary mold metabolites.47.Isolation and structure elucidation of clavilactones AC,new metabolites from the fungus Clitocybe clavipes[J].J Chem Soc Perkin Trans,1994(15):2165-2168.
[35]Meir N,Klaebc A,Chavant L,et al.Insecticidal properties of mushroom and toadstool carpophores[J].Phytochem,1996,41(5):1293-1299.
[36]Wang,M,Trigueros V,Paquereau L,et al.Proteins as active compounds involved in insecticidal activity of mushroom fruitbodies[J].J Econom Entomol,2002,95(3):603-607.
[37]Triguéros V,Lougarre A,Ali-Ahmed D,et al.Xerocomus chrysenteron lectin:identification of a new pesticidal protein[J].Biochim Biophys Acta,2003,1621(3):292-298.
[38]Nawrot J,Bloszyk E,Harmatha J,et al.Action of antifeedants of plant origin on beetles infecting stored products[J].Acta Entomolog Bohemoslovaca,1986(83):327-335.
[39]Conca E,De Bernardi M,Fronza G,et al.Fungal metabolites 10.New chromenes from Lactarius fuliginosus and Lactarius picinus Fries[J].Tetrahedr Lett,1981(22):4327-4330.
[40]Allievi C.De Bernardi M,Demarchi F,et al.Chromatographic analysis of 2,2-dimethylchromene derivatives[J].JChromatography,1983(261):331-341.
[41]Bowers WS.Discovery of insect antiallatotropins[A].In:Gilbert LI,editor.The juvenile hormones[M].New York(NY):Plenum Press,1976:394-408.
[42]Dowd PF,Miller OK.Insecticidal properties of Lactarius fuliginosus and Lactarius fumosus[J].Entomol Experiment Applic,1990(57):23-28.
[43]Bücker A,Bücker NCF,Lima de Souza AQ,et al.Larvicidal effects of endophytic and basidiomycete fungus extracts on Aedes and Anopheles larvae(Diptera,Culicidae)[J].Rev Soc Brasil Med Trop,2013,46(4):411-419.
[44]Mayer A,Sterner O,Anke H.Omphalotin,a new cyclic peptide with potent nematicidal activity from Omphalotus olearius.1.Fermentation and biological activity[J].Nat Prod Lett,1997(10):25-33.
[45]Lambert M,Kremer S,Anke H.Antimicrobial,phytotoxic,nematicidal,cytotoxic,and mutagenic activities of 1-hydroxypyrene,the initial metabolite in pyrene metabolism by the basidiomycete Crinipellis stipitaria[J].Bull Environ Contam Toxicol,1995(55):521-557.
[46]Dong JY,Li XP,Li L,et al.Preliminary results on nematocidal activity from culture filtrates of Basidiomycetes against the pine wood nematode,Bursaphelenchus xylophilus(Aphelenchoididae)[J].Ann Microbiol,2006(56):163-166.
[47]Barseghyan GS,Barazani A,Wasser SP.Chapter 8.Medicinal mushrooms with anti-phytopathogenic and insecticidal properties[A].In Petre M,editor.Mushroom biotechnology,1st ed.New York(NY):Academic Press,2016:137-154.
[48]Wasser SP.Medicinal mushroom science:history,current status,future trends,and unsolved problems[J].Int J Med Mushrooms,2010,12(1):1-16.
[49]Gargano ML,Griensven LJLD,Isikhuemhen OS,et al.Medicinal mushrooms:valuable biological resources of high exploitation potential[J].Plant Biosyst,2017,151(3):548-565.
[50]Wasser SP.Medicinal mushroom science:current perspectives,advances and challenges[J].Biomed J,2014,37(6):345-368.
[51]Griensven LJLD.Culinary-medicinal mushrooms:must action be taken[J].Int J Med Mushrooms,2009,11(3):281-286.
[52]Lindequist U.The merit of medicinal mushrooms from a pharmaceutical point of view[J].Int J Med Mushrooms,2013,15(6):517-523.
[53]Wasser SP.Medicinal mushrooms in human clinical studies.Part I.anticancer,oncoimmunological,and immunomodulatory activities:a review[J].Int J Med Mushrooms,2017,19(4):279-317.